Zhou Y, Guo Y, Zhou R, Wu P, Liang F, Yang Z
The tenosynovium (tendon sheath) benefits from enhanced healing while the tendons themselves undergo repair and strengthening
Thus, we suggest that one single application of the NO-synthase (NOS) blocker N(G)-nitro-L-arginine methyl ester (L-NAME) may induce retinal ischemia in rats, and that the stable pentadecapeptide BPC 157 may be the therapy, since it may interact with the NO-system and may counteract various adverse effects of L-NAME application (see Wu et al., 2020) [i.e., activation of the VEGFR2-Akt-eNOS signaling pathway without the need of other known ligands or shear stress ( In the previous eye research studies, BPC 157 counteracts atropine-mydriasis, but it also opposes an immediate and hour-lasting miotic effect of L-NAME in rats and guinea pigs, and participates in pupil control potentially via NO-mediated and cholinergic mechanisms ( This may be essential for the effective counteraction of the damaging effect of the retrobulbar L-NAME application
Frequently asked questions Is penta deca peptide arginate the same as BPC-157
This combined peptide formulation is studied in research settings for its potential relevance in tissue repair models, cellular regeneration pathways, and recovery-focused biochemical research
